Izumi, Namiki http://orcid.org/0000-0002-0055-8229
Takehara, Tetsuo
Chayama, Kazuaki
Yatsuhashi, Hiroshi
Takaguchi, Koichi
Ide, Tatsuya
Kurosaki, Masayuki
Ueno, Yoshiyuki
Toyoda, Hidenori
Kakizaki, Satoru
Tanaka, Yasuhito
Kawakami, Yoshiiku
Enomoto, Hirayuki
Ikeda, Fusao
Jiang, Deyuan
De-Oertel, Shampa
McNabb, Brian L.
Camus, Gregory
Stamm, Luisa M.
Brainard, Diana M.
McHutchison, John G.
Mochida, Satoshi
Mizokami, Masashi
Funding for this research was provided by:
Gilead Sciences
Article History
Received: 30 January 2018
Accepted: 1 June 2018
First Online: 20 July 2018
Compliance with ethical standards
:
: Namiki Izumi: Gilead, AbbVie, Otsuka, Shionogi, and Bayer. Consultant: Kowa, Shionogi, Gilead, AbbVie, and Eizai (Speaker). Tetsuo Takehara: Gilead (Research support funding and lecturer). Kazuaki Chayama: AbbVie, MSD, BMS, and Gilead (Speaker). Hiroshi Yatsuhashi: Chugai (Research grant). Koichi Takaguchi: AbbVie, Bristol-Myer Squib, Astra-Zeneka KK (Speaker). Tatsuya Ide: Gilead, and Abbvie (Speaker). Masayuki Kurosaki: AbbVie, Bristol-Myers Squibb, Chugai, Daiichi Sankyo, Gilead Sciences, GlaxoSmithKline, Janssen, Merck, Otsuka, and Toray (Speaker). AbbVie, Gilead Sciences, GlaxoSmithKline, and Otsuka (Scientific advisor). Yoshiyuki Ueno: Gilead Sciences, Inc, BMS, Abbvie, MSD (Research grant). Hidenori Toyoda: Gilead Sciences, AbbVie, Bristol-Meyers Squibb, MSD, Sysmex, WAKO, Bayer Pharma, and Abbott (Speaker). Satoru Kakizaki: AbbVie, BMS, Gilead, and MSD. Research grant: AbbVie, BMS, Gilead, and MSD (Speaker). Yasuhito Tanaka: Gilead and Janssen (Advisory committees or review panels). Chugai Pharmaceutical Co., Ltd., Abbvie, Bristol-Myers Squibb, Janssen, and Gilead Sciences (Grant/research support). Bristol-Myers Squibb and Gilead Sciences (Speaking and Teaching). Yoshiiku Kawakami: None. Hirayuki Enomoto: None. Fusao Ikeda: None. Satoshi Mochida: SRL Inc. (Royalties). Bristol-Myers Squibb, Toray Medical Co. Ltd., Ajinomoto Pharmaceuticals Co. Ltd., MSD K.K. (Lecture Fees). Bristol-Myers Squibb, Tanabe Mitsubishi Pharma Co. Ltd., MSD K.K. (Consigned/joint research expenses). Bristol-Myers Squibb, MSD K.K., Toray Medical Co. Ltd., Chugai Pharmaceutical Co. Ltd., Eisai Co. Ltd., and Takeda Phamaceutical Co. Ltd. (Scholarship Donations). Masashi Mizokami: Gilead and Sysmex (Speaker). Gilead and Sysmex (Consultant). Deyuan Jiang, Shampa De-Oertel, Gregory Camus, Luisa M. Stamm, Diana M. Brainard, and John G. McHutchison are employees of and own stock in Gilead Sciences, Inc. Brian McNabb owns stock in Gilead Sciences, and was an employee of Gilead at the time which the study was conducted. He is an employee of and owns stock in DocMatter.com.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.